Annual Shareholders Equity
-$2.31 M
-$25.36 M-110.03%
31 December 2023
Summary:
Lucid Diagnostics annual stockholders equity is currently -$2.31 million, with the most recent change of -$25.36 million (-110.03%) on 31 December 2023. During the last 3 years, it has risen by +$11.21 million (+82.90%). LUCD annual shareholders equity is now -104.22% below its all-time high of $54.74 million, reached on 31 December 2021.LUCD Shareholders Equity Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Shareholders Equity
$6.34 M
-$9.64 M-60.34%
30 September 2024
Summary:
Lucid Diagnostics quarterly stockholders equity is currently $6.34 million, with the most recent change of -$9.64 million (-60.34%) on 30 September 2024. Over the past year, it has increased by +$3.78 million (+147.97%). LUCD quarterly shareholders equity is now -88.42% below its all-time high of $54.74 million, reached on 31 December 2021.LUCD Quarterly Shareholders Equity Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
LUCD Shareholders Equity Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -110.0% | +148.0% |
| 3 y3 years | +82.9% | +126.3% |
| 5 y5 years | - | - |
LUCD Shareholders Equity High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | -104.2% | +82.9% | -88.4% | +126.3% |
| 5 y | 5 years | -104.2% | +82.9% | -88.4% | +126.3% |
| alltime | all time | -104.2% | +82.9% | -88.4% | +126.3% |
Lucid Diagnostics Shareholders Equity History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $6.34 M(-60.3%) |
| June 2024 | - | $15.98 M(+34.3%) |
| Mar 2024 | - | $11.89 M(-614.7%) |
| Dec 2023 | -$2.31 M(-110.0%) | -$2.31 M(-190.4%) |
| Sept 2023 | - | $2.56 M(-83.0%) |
| June 2023 | - | $15.07 M(-39.5%) |
| Mar 2023 | - | $24.91 M(+8.1%) |
| Dec 2022 | $23.05 M | $23.05 M(-16.3%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2022 | - | $27.53 M(-24.0%) |
| June 2022 | - | $36.24 M(-22.0%) |
| Mar 2022 | - | $46.49 M(-15.1%) |
| Dec 2021 | $54.74 M(-504.9%) | $54.74 M(-326.8%) |
| Sept 2021 | - | -$24.13 M(+21.0%) |
| June 2021 | - | -$19.95 M(+47.6%) |
| Dec 2020 | -$13.52 M(+154.6%) | -$13.52 M |
| Dec 2019 | -$5.31 M | - |
FAQ
- What is Lucid Diagnostics annual stockholders equity?
- What is the all time high annual shareholders equity for Lucid Diagnostics?
- What is Lucid Diagnostics annual shareholders equity year-on-year change?
- What is Lucid Diagnostics quarterly stockholders equity?
- What is the all time high quarterly shareholders equity for Lucid Diagnostics?
- What is Lucid Diagnostics quarterly shareholders equity year-on-year change?
What is Lucid Diagnostics annual stockholders equity?
The current annual shareholders equity of LUCD is -$2.31 M
What is the all time high annual shareholders equity for Lucid Diagnostics?
Lucid Diagnostics all-time high annual stockholders equity is $54.74 M
What is Lucid Diagnostics annual shareholders equity year-on-year change?
Over the past year, LUCD annual stockholders equity has changed by -$25.36 M (-110.03%)
What is Lucid Diagnostics quarterly stockholders equity?
The current quarterly shareholders equity of LUCD is $6.34 M
What is the all time high quarterly shareholders equity for Lucid Diagnostics?
Lucid Diagnostics all-time high quarterly stockholders equity is $54.74 M
What is Lucid Diagnostics quarterly shareholders equity year-on-year change?
Over the past year, LUCD quarterly stockholders equity has changed by +$3.78 M (+147.97%)